Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the clinical effectiveness of intravenous esomeprazole
and pantoprazole in preventing recurrent bleeding in the patients with high-risk bleeding
peptic ulcers after successful standard endoscopic hemostasis.